Autres langues Novo Nordisk A/S

Actions

Marché Fermé - Nasdaq Copenhagen Autres places de cotation 16:59:56 26/04/2024			Varia. 5j.	Varia. 1 janv.
886,6 ^DKK	+2,28%		+2,36%	+27,00%

26/04	Agenda : Apple, Amazon, Eli Lilly et Stellantis arrivent !
25/04	NOVO NORDISK : JP Morgan optimiste sur le dossier	ZD

WOCHENVORSCHAU: Termine bis 10. Mai 2024	26/04
WOCHENVORSCHAU/29. April bis 5. Mai (18. KW)	26/04
Nonalcoholic Steatohepatitis Market to Observe Impressive Growth During the Forecast Period \| Inventiva Pharma, Zydus Therapeutics, Novo Nordisk A/S, Eli Lilly and Company, Madrigal Pharmaceuticals	26/04
Scholz verspricht Pharma-Branche bei Merck weitere Unterstützung	25/04
Scholz promises support for pharma sector in Germany as Merck invests	25/04
Sector Update: Health Care Stocks Slipping Late Afternoon	24/04
Sector Update: Health Care	24/04
Comisión del Senado de EEUU investiga precios de medicamentos para adelgazar Ozempic y Wegovy	24/04
Novo Nordisk's Wegovy FDA Approval for Heart Health Opens Door to Medicare Access, KKF Says	24/04
US Senate committee investigates pricing of Novo's Ozempic and Wegovy	24/04
Novo Nordisk Probed by Senate Committee on Weight-Loss Drug Prices	24/04
Novo Nordisk A/S : Reduction of the share capital	24/04
Novo Nordisk A/S - Articles of Association, April 2024	24/04
Novo Nordisk A/S – Reduction of the share capital	24/04
Germany's Evotec appoints Christian Wojczewski as CEO	23/04
UK stocks may finally be back in fashion	23/04
Health Care Climbs on Earnings Hopes -- Health Care Roundup	22/04
Eli Lilly to acquire manufacturing facility from Nexus Pharma	22/04
Novo Nordisk A/S - share repurchase programme	22/04
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut	21/04